(Q33202271)

23 July 2017

title

Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression (English)

1 reference

acute promyelocytic leukemia

23 July 2017

main subject

1 reference

Daniela Damiani

1

1 reference

23 July 2017

Mariagrazia Michieli

2

1 reference

23 July 2017

Angela Michelutti

3

1 reference

23 July 2017

Anna Candoni

4

1 reference

23 July 2017

Raffaella Stocchi

5

1 reference

23 July 2017

Paola Masolini

6

1 reference

23 July 2017

Antonella Geromin

7

1 reference

23 July 2017

Teresa Michelutti

8

1 reference

23 July 2017

Donatella Raspadori

9

1 reference

23 July 2017

Micaela Ippoliti

10

1 reference

23 July 2017

Francesco Lauria

11

1 reference

23 July 2017

Renato Fanin

12

1 reference

23 July 2017

publication date

1 May 2004

1 reference

Cytometry Part B: Clinical Cytometry

23 July 2017

published in

1 reference

23 July 2017

volume

59

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

40-45

1 reference

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Chemotherapy resistance in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Emergence of multidrug resistance in leukemia cells during chemotherapy: mechanisms and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

The role of drug efflux pumps in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Acute promyelocytic leukemia: evolving therapeutic strategies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Treatment options for relapsed acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

CD 45 gating correlates with bone marrow differential

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Significance of lung resistance-related protein in the clinical outcome of acute leukaemic patients with reference to P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Advances in the treatment of relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Arsenic trioxide: mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20006

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20006

1 reference

23 July 2017

1 reference